A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/135 (2006.01) A61K 31/138 (2006.01)
Patent
CA 2209735
Tomoxetine, a norepinephrine uptake inhibitor, is used to treat attention- deficit/hyperactivity disorder.
On utilise la tomoxétine, inhibiteur de la captation de norépinephrine, afin de traiter un trouble déficitaire de l'attention de l'hyperactivité.
Heiligenstein John Harrison
Tollefson Gary Dennis
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Treatment of attention-deficit/hyperactivity disorder does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of attention-deficit/hyperactivity disorder, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of attention-deficit/hyperactivity disorder will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1875109